Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 What if gut hormones aren't really hormones: DPP-4 inhibition and local action of GLP-1 in the gastrointestinal tract.

Literature DB >> 21785013

What if gut hormones aren't really hormones: DPP-4 inhibition and local action of GLP-1 in the gastrointestinal tract.

David A D'Alessio¹.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2011 PMID： 21785013 PMCID： PMC3138230 DOI： 10.1210/en.2011-1385

Source DB: PubMed Journal: Endocrinology ISSN： 0013-7227 Impact factor: 4.736

× No keyword cloud information.

13 in total

Review 1. Incretin-based therapies for type 2 diabetes mellitus.

Authors: Julie A Lovshin; Daniel J Drucker
Journal: Nat Rev Endocrinol Date: 2009-05 Impact factor: 43.330

2. Physiological and pharmacological mechanisms through which the DPP-4 inhibitor sitagliptin regulates glycemia in mice.

Authors: Aurélie Waget; Cendrine Cabou; Myriam Masseboeuf; Pierre Cattan; Mattieu Armanet; Mélis Karaca; Julien Castel; Celine Garret; Gaëlle Payros; Adriano Maida; Thierry Sulpice; Jens J Holst; Daniel J Drucker; Christophe Magnan; Rémy Burcelin
Journal: Endocrinology Date: 2011-06-14 Impact factor: 4.736

3. Glucose competence of the hepatoportal vein sensor requires the presence of an activated glucagon-like peptide-1 receptor.

Authors: R Burcelin; A Da Costa; D Drucker; B Thorens
Journal: Diabetes Date: 2001-08 Impact factor: 9.461

4. Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine.

Authors: L Hansen; C F Deacon; C Orskov; J J Holst
Journal: Endocrinology Date: 1999-11 Impact factor: 4.736

Review 5. Biology of incretins: GLP-1 and GIP.

Authors: Laurie L Baggio; Daniel J Drucker
Journal: Gastroenterology Date: 2007-05 Impact factor: 22.682

6. Fasting and postprandial concentrations of GLP-1 in intestinal lymph and portal plasma: evidence for selective release of GLP-1 in the lymph system.

Authors: David D'Alessio; Wendell Lu; William Sun; Shuqin Zheng; Qing Yang; Randy Seeley; Stephen C Woods; Patrick Tso
Journal: Am J Physiol Regul Integr Comp Physiol Date: 2007-09-26 Impact factor: 3.619

7. Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats.

Authors: Torsten P Vahl; Miyuki Tauchi; Timothy S Durler; Eileen E Elfers; Timothy M Fernandes; Ronald D Bitner; Kay S Ellis; Stephen C Woods; Randy J Seeley; James P Herman; David A D'Alessio
Journal: Endocrinology Date: 2007-06-21 Impact factor: 4.736

Review 8. Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis.

Authors: Renee E Amori; Joseph Lau; Anastassios G Pittas
Journal: JAMA Date: 2007-07-11 Impact factor: 56.272

9. The effect of DPP-4 inhibition with sitagliptin on incretin secretion and on fasting and postprandial glucose turnover in subjects with impaired fasting glucose.

Authors: Gerlies Bock; Chiara Dalla Man; Francesco Micheletto; Rita Basu; Paula D Giesler; Jeanette Laugen; Carolyn F Deacon; Jens J Holst; Gianna Toffolo; Claudio Cobelli; Robert A Rizza; Adrian Vella
Journal: Clin Endocrinol (Oxf) Date: 2009-12-18 Impact factor: 3.478

10. Genetic tracing of Nav1.8-expressing vagal afferents in the mouse.

Authors: Laurent Gautron; Ichiro Sakata; Swalpa Udit; Jeffrey M Zigman; John N Wood; Joel K Elmquist
Journal: J Comp Neurol Date: 2011-10-15 Impact factor: 3.215

14 in total

1. β-Cell Sensitivity to GLP-1 in Healthy Humans Is Variable and Proportional to Insulin Sensitivity.

Authors: Benedikt A Aulinger; Torsten P Vahl; Hilary E Wilson-Pérez; Ron L Prigeon; David A D'Alessio
Journal: J Clin Endocrinol Metab Date: 2015-03-31 Impact factor: 5.958

2. The role of β cell glucagon-like peptide-1 signaling in glucose regulation and response to diabetes drugs.

Authors: Eric P Smith; Zhibo An; Constance Wagner; Alfor G Lewis; Eric B Cohen; Bailing Li; Parinaz Mahbod; Darleen Sandoval; Diego Perez-Tilve; Natalia Tamarina; Louis H Philipson; Doris A Stoffers; Randy J Seeley; David A D'Alessio
Journal: Cell Metab Date: 2014-05-15 Impact factor: 27.287

Review 3. Dipeptidyl peptidase-4 inhibitors: Novel mechanism of actions.

Authors: Awadhesh Kumar Singh
Journal: Indian J Endocrinol Metab Date: 2014-11

4. Effects of glucose-dependent insulinotropic polypeptide on gastric emptying, glycaemia and insulinaemia during critical illness: a prospective, double blind, randomised, crossover study.

Authors: Palash Kar; Caroline E Cousins; Christopher E Annink; Karen L Jones; Marianne J Chapman; Juris J Meier; Michael A Nauck; Michael Horowitz; Adam M Deane
Journal: Crit Care Date: 2015-01-23 Impact factor: 9.097

10. The serine protease, dipeptidyl peptidase IV as a myokine: dietary protein and exercise mimetics as a stimulus for transcription and release.

Authors: Leslie E Neidert; C Brooks Mobley; Wesley C Kephart; Michael D Roberts; Heidi A Kluess
Journal: Physiol Rep Date: 2016-06